With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Researchers engineer a hydrogel that recapitulates biophysical changes in the tissues surrounding tumors to investigate how tissue stiffness impacts the mobility of invasive and non-invasive cancer cells.
Electrospinning is an emerging fabrication technology that holds great promise in advancing skin tissue engineering and in developing an array of novel therapies.
Older individuals in low- and middle-income countries are considered to be the most vulnerable to COVID-19 but have yet to be properly acknowledged in global planning for the disease.
One drug, three modes of action: Clinicians combat the drug resistances of some cancer types by using a combination of different drugs.
A new take on CRISPR allows researchers to “paint” cells and observe never-before-seen cellular processes in great detail.
A new smart bandage is effective in the treatment of chronic wounds brought about by diabetes.
New research published in CANCER indicates that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer.
Although it is essential to develop vaccines for the 2019 coronavirus, it is unlikely that any effort made at the moment will benefit patients in the current outbreak.
The current barriers of CRISPR/Cas9 delivery and promising development of nanoparticle-based approaches for precise gene editing.
Researchers in labs around the world use the latest techniques to combat the Wuhan coronavirus.
Researchers at the University of Illinois at Urbana-Champaign develop an energy-efficient device for purifying arsenic-contaminated water.